P53/miR-154 Pathway Regulates the Epithelial-Mesenchymal Transition in Glioblastoma Multiforme Cells by Targeting TCF12

References

• Mooney J, Bernstock JD, Ilyas A, et al. Current approaches and challenges in the molecular therapeutic targeting of glioblastoma. World Neurosurg. 2019;129:90–100. doi:10.1016/j.wneu.2019.05.20531152883
   PubMed Web of Science ®Google Scholar
• Brown TJ, Brennan MC, Li M, et al. Association of the extent of resection with survival in glioblastoma: a systematic review and meta-analysis. JAMA oncol. 2016;2(11):1460–1469. doi:10.1001/jamaoncol.2016.137327310651
   PubMed Web of Science ®Google Scholar
• Sanai N, Berger MS. Surgical oncology for gliomas: the state of the art. Nat Rev Clin Oncol. 2017;15(2):112–125. doi:10.1038/nrclinonc.2017.17129158591
   PubMed Web of Science ®Google Scholar
• Iwadate Y. Epithelial-mesenchymal transition in glioblastoma progression. Oncol Lett. 2016;11(3):1615–1620. doi:10.3892/ol.2016.411326998052
   PubMed Web of Science ®Google Scholar
• Wang J, Zhang KY, Liu SM, Sen S. Tumor-associated circulating microRNAs as biomarkers of cancer. Molecules. 2014;19(2):1912–1938. doi:10.3390/molecules1902191224518808
   PubMed Web of Science ®Google Scholar
• O’Brien J, Hayder H, Zayed Y, Peng C. Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation. Front Endocrinol. 2018;9:402. doi:10.3389/fendo.2018.00402
   PubMed Web of Science ®Google Scholar
• Kumar S, Reddy AP, Yin X, Reddy PH. Novel MicroRNA-455-3p and its protective effects against abnormal APP processing and amyloid beta toxicity in Alzheimer’s disease. Biochimica Et Biophysica Acta Mol Basis Dis. 2019;1865(9):2428–2440. doi:10.1016/j.bbadis.2019.06.006
   PubMed Web of Science ®Google Scholar
• Subramaniam S, Jeet V, Clements JA, Gunter JH, Batra J. Emergence of MicroRNAs as Key Players in Cancer Cell Metabolism. Clin Chem. 2019;65(9):1090–1101. doi:10.1373/clinchem.2018.29965131101638
   PubMed Web of Science ®Google Scholar
• Kumar Kingsley SM, Vishnu Bhat B. Role of MicroRNAs in the development and function of innate immune cells. Int Rev Immunol. 2017;36(3):154–175. doi:10.1080/08830185.2017.128421228471289
   PubMed Web of Science ®Google Scholar
• Lo Sardo F, Forcato M, Sacconi A, et al. MCM7 and its hosted miR-25, 93 and 106b cluster elicit YAP/TAZ oncogenic activity in lung cancer. Carcinogenesis. 2017;38(1):64–75. doi:10.1093/carcin/bgw11027797825
   PubMed Web of Science ®Google Scholar
• Wu P, Cai J, Chen Q, et al. Lnc-TALC promotes O(6)-methylguanine-DNA methyltransferase expression via regulating the c-Met pathway by competitively binding with miR-20b-3p. Nat Commun. 2019;10(1):2045. doi:10.1038/s41467-019-10025-231053733
   PubMed Web of Science ®Google Scholar
• Banelli B, Forlani A, Allemanni G, Morabito A, Pistillo MP, Romani M. MicroRNA in Glioblastoma: an Overview. Int J Genomics. 2017;2017:7639084. doi:10.1155/2017/763908429234674
   PubMed Web of Science ®Google Scholar
• Lingling J, Xiangao J, Guiqing H, Jichan S, Feifei S, Haiyan Z. SNHG20 knockdown suppresses proliferation, migration and invasion, and promotes apoptosis in non-small cell lung cancer through acting as a miR-154 sponge. Biomed Pharmacother. 2019;112:108648. doi:10.1016/j.biopha.2019.10864830780105
   PubMed Web of Science ®Google Scholar
• Xu M, Chen X, Lin K, et al. The long noncoding RNA SNHG1 regulates colorectal cancer cell growth through interactions with EZH2 and miR-154-5p. Mol Cancer. 2018;17(1):141. doi:10.1186/s12943-018-0894-x30266084
   PubMed Web of Science ®Google Scholar
• Wang J, Fang Y, Liu YF, et al. MiR-154 inhibits cells proliferation and metastasis in melanoma by targeting AURKA and serves as a novel prognostic indicator. Eur Rev Med Pharmacol Sci. 2019;23(10):4275–4284. doi:10.26355/eurrev_201905_1793231173299
   PubMed Web of Science ®Google Scholar
• Yang L, Yan Z, Wang Y, Ma W, Li C. Down-expression of miR-154 suppresses tumourigenesis in CD133(+) glioblastoma stem cells. Cell Biochem Funct. 2016;34(6):404–413. doi:10.1002/cbf.320127338789
   PubMed Web of Science ®Google Scholar
• Wang X, Sun S, Tong X, et al. MiRNA-154-5p inhibits cell proliferation and metastasis by targeting PIWIL1 in glioblastoma. Brain Res. 2017;1676:69–76. doi:10.1016/j.brainres.2017.08.01428842123
   PubMed Web of Science ®Google Scholar
• Parsons DW, Jones S, Zhang X, et al. An integrated genomic analysis of human glioblastoma multiforme. Science. 2008;321(5897):1807–1812. doi:10.1126/science.116438218772396
   PubMed Web of Science ®Google Scholar
• England B, Huang T, Karsy M. Current understanding of the role and targeting of tumor suppressor p53 in glioblastoma multiforme. Tumour Biol. 2013;34(4):2063–2074. doi:10.1007/s13277-013-0871-323737287
   PubMed Web of Science ®Google Scholar
• Chen L, Jiang Z, Ma H, et al. Volatile oil of Acori Graminei Rhizoma-Induced apoptosis and Autophagy are dependent on p53 Status in Human Glioma Cells. Sci Rep. 2016;6(1):21148. doi:10.1038/srep2114826892186
   PubMed Web of Science ®Google Scholar
• Khoo KH, Verma CS, Lane DP. Drugging the p53 pathway: understanding the route to clinical efficacy. Nat Rev Drug Discov. 2014;13(3):217–236.24577402
   PubMed Web of Science ®Google Scholar
• Wu CW, Peng ML, Yeh KT, Tsai YY, Chiang CC, Cheng YW. Inactivation of p53 in pterygium influence miR-200a expression resulting in ZEB1/ZEB2 up-regulation and EMT processing. Exp Eye Res. 2016;146:206–211. doi:10.1016/j.exer.2016.03.01226995143
   PubMed Web of Science ®Google Scholar
• Chen J, Wang J, Li H, Wang S, Xiang X, Zhang D. p53 activates miR-192-5p to mediate vancomycin induced AKI. Sci Rep. 2016;6:38868. doi:10.1038/srep3886827941921
   PubMed Web of Science ®Google Scholar
• Moscetti I, Cannistraro S, Bizzarri AR. Probing direct interaction of oncomiR-21-3p with the tumor suppressor p53 by fluorescence, FRET and atomic force spectroscopy. Arch Biochem Biophys. 2019;671:35–41. doi:10.1016/j.abb.2019.05.02631181181
   PubMed Web of Science ®Google Scholar
• Zhang B, Wang X, Deng J, et al. p53-dependent upregulation of miR-16-2 by sanguinarine induces cell cycle arrest and apoptosis in hepatocellular carcinoma. Cancer Lett. 2019;459:50–58. doi:10.1016/j.canlet.2019.05.04231163195
   PubMed Web of Science ®Google Scholar
• Tang X, Hou Y, Yang G, et al. Stromal miR-200s contribute to breast cancer cell invasion through CAF activation and ECM remodeling. Cell Death Differ. 2016;23(1):132–145. doi:10.1038/cdd.2015.7826068592
   PubMed Web of Science ®Google Scholar
• He J, Shen S, Lu W, et al. HDAC1 promoted migration and invasion binding with TCF12 by promoting EMT progress in gallbladder cancer. Oncotarget. 2016;7(22):32754–32764. doi:10.18632/oncotarget.874027092878
   PubMedGoogle Scholar
• Zhu G, Tao L, Wang R, et al. Endoplasmic reticulum stress mediates distinct impacts of sevoflurane on different subfields of immature hippocampus. J Neurochem. 2017;142(2):272–285. doi:10.1111/jnc.1405728444766
   PubMed Web of Science ®Google Scholar
• Wang J, Zhu G, Huang L, et al. Morphine administration induces change in anxiety-related behavior via Wnt/beta-catenin signaling. Neurosci Lett. 2017;639:199–206. doi:10.1016/j.neulet.2017.01.00528063934
   PubMed Web of Science ®Google Scholar
• Crane EK, Kwan SY, Izaguirre DI, et al. Nutlin-3a: a Potential Therapeutic Opportunity for TP53 Wild-Type Ovarian Carcinomas. PLoS One. 2015;10(8):e0135101. doi:10.1371/journal.pone.013510126248031
   PubMed Web of Science ®Google Scholar
• Lin C, Li Z, Chen P, et al. Oncogene miR-154-5p regulates cellular function and acts as a molecular marker with poor prognosis in renal cell carcinoma. Life Sci. 2018;209:481–489. doi:10.1016/j.lfs.2018.08.04430138594
   PubMed Web of Science ®Google Scholar
• Sun HY, Wang XL, Ma LC, et al. Influence of MiR-154 on myocardial apoptosis in rats with acute myocardial infarction through Wnt/beta-catenin signaling pathway. Eur Rev Med Pharmacol Sci. 2019;23(2):818–825. doi:10.26355/eurrev_201901_1689630720190
   PubMed Web of Science ®Google Scholar
• Haftmann C, Stittrich AB, Zimmermann J, et al. miR-148a is upregulated by Twist1 and T-bet and promotes Th1-cell survival by regulating the proapoptotic gene Bim. Eur J Immunol. 2015;45(4):1192–1205. doi:10.1002/eji.20144463325486906
   PubMed Web of Science ®Google Scholar
• Duan Y, Chen Q. TGF-beta1 regulating miR-205/miR-195 expression affects the TGF-beta signal pathway by respectively targeting SMAD2/SMAD7. Oncol Rep. 2016;36(4):1837–1844. doi:10.3892/or.2016.502327574009
   PubMed Web of Science ®Google Scholar
• Bianchi E, Bulgarelli J, Ruberti S, et al. MYB controls erythroid versus megakaryocyte lineage fate decision through the miR-486-3p-mediated downregulation of MAF. Cell Death Differ. 2015;22(12):1906–1921. doi:10.1038/cdd.2015.3025857263
   PubMed Web of Science ®Google Scholar
• Milosevic J, Pandit K, Magister M, et al. Profibrotic role of miR-154 in pulmonary fibrosis. Am J Respir Cell Mol Biol. 2012;47(6):879–887. doi:10.1165/rcmb.2011-0377OC23043088
   PubMed Web of Science ®Google Scholar
• Zhang Y, Dube C, Gibert M, et al. The p53 Pathway in Glioblastoma. Cancers. 2018;10(9):9. doi:10.3390/cancers10090297
   Web of Science ®Google Scholar
• Doan P, Musa A, Candeias NR, Emmert-Streib F, Yli-Harja O, Kandhavelu M. Alkylaminophenol Induces G1/S Phase Cell Cycle Arrest in Glioblastoma Cells Through p53 and Cyclin-Dependent Kinase Signaling Pathway. Front Pharmacol. 2019;10:330. doi:10.3389/fphar.2019.0033031001122
   PubMed Web of Science ®Google Scholar
• Kruiswijk F, Labuschagne CF, Vousden KH. p53 in survival, death and metabolic health: a lifeguard with a licence to kill. Nat Rev Mol Cell Biol. 2015;16(7):393–405. doi:10.1038/nrm400726122615
   PubMed Web of Science ®Google Scholar
• Guo SL, Ye H, Teng Y, et al. Akt-p53-miR-365-cyclin D1/cdc25A axis contributes to gastric tumorigenesis induced by PTEN deficiency. Nat Commun. 2013;4(1):2544. doi:10.1038/ncomms354424149576
   PubMed Web of Science ®Google Scholar
• Renner G, Janouskova H, Noulet F, et al. Integrin alpha5beta1 and p53 convergent pathways in the control of anti-apoptotic proteins PEA-15 and survivin in high-grade glioma. Cell Death Differ. 2016;23(4):640–653. doi:10.1038/cdd.2015.13126470725
   PubMed Web of Science ®Google Scholar
• Liu S, Yang Y, Chen L, Liu D, Dong H. MicroRNA-154 functions as a tumor suppressor in non-small cell lung cancer through directly targeting B-cell-specific Moloney murine leukemia virus insertion site 1. Oncol Lett. 2018;15(6):10098–10104.29928380
   PubMed Web of Science ®Google Scholar
• Xu H, Fei D, Zong S, Fan Z. MicroRNA-154 inhibits growth and invasion of breast cancer cells through targeting E2F5. Am J Transl Res. 2016;8(6):2620–2630.27398145
   PubMed Web of Science ®Google Scholar
• Yi S, Yu M, Yang S, Miron RJ, Zhang Y. Tcf12, A member of basic helix-loop-helix transcription factors, mediates bone marrow mesenchymal stem cell osteogenic differentiation in vitro and in vivo. Stem Cells. 2017;35(2):386–397. doi:10.1002/stem.249127574032
   PubMed Web of Science ®Google Scholar
• Sjogren H, Wedell B, Meis-Kindblom JM, Kindblom LG, Stenman G, Kindblom JM. Fusion of the NH2-terminal domain of the basic helix-loop-helix protein TCF12 to TEC in extraskeletal myxoid chondrosarcoma with translocation t(9;15)(q22;q21). Cancer Res. 2000;60(24):6832–6835.11156374
   PubMed Web of Science ®Google Scholar
• Wang X, Gao S, Xie F, et al. High expression of TCF12 contributes to gastric cancer development via being target regulated by miR-183 and activating PI3K/AKT pathway. J Cell Biochem. 2019;120:13903.30982999
   PubMed Web of Science ®Google Scholar
• Chen Y, Wang Q, Wang Q, et al. DEAD-box helicase 5 interacts with transcription factor 12 and promotes the progression of osteosarcoma by stimulating cell cycle progression. Front Pharmacol. 2018;9:1558. doi:10.3389/fphar.2018.0155830733679
   PubMed Web of Science ®Google Scholar
• Lee CC, Chen WS, Chen CC, et al. TCF12 protein functions as transcriptional repressor of E-cadherin, and its overexpression is correlated with metastasis of colorectal cancer. J Biol Chem. 2012;287(4):2798–2809. doi:10.1074/jbc.M111.25894722130667
   PubMed Web of Science ®Google Scholar